BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 22521321)

  • 1. Relationship between DDAH gene variants and serum ADMA level in individuals with type 1 diabetes.
    Fogarty RD; Abhary S; Javadiyan S; Kasmeridis N; Petrovsky N; Whiting MJ; Craig JE; Burdon KP
    J Diabetes Complications; 2012; 26(3):195-8. PubMed ID: 22521321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sequence variation in DDAH1 and DDAH2 genes is strongly and additively associated with serum ADMA concentrations in individuals with type 2 diabetes.
    Abhary S; Burdon KP; Kuot A; Javadiyan S; Whiting MJ; Kasmeridis N; Petrovsky N; Craig JE
    PLoS One; 2010 Mar; 5(3):e9462. PubMed ID: 20209122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic variation in the dimethylarginine dimethylaminohydrolase 1 gene (DDAH1) is related to asymmetric dimethylarginine (ADMA) levels, but not to endothelium-dependent vasodilation.
    Lind L; Ingelsson E; Kumar J; Syvänen AC; Axelsson T; Teerlink T
    Vasc Med; 2013 Aug; 18(4):192-9. PubMed ID: 23892448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ADMA, SDMA and L-arginine/ADMA ratio but not DDAH genetic polymorphisms are reliable predictors of diabetic nephropathy progression as identified by competing risk analysis.
    Tanhäuserová V; Tomandl J; Pácal L; Klepárník M; Malúšková D; Bartáková V; Kuricová K; Rehořová J; Stěpánková S; Svojanovský J; Olšovský J; Bělobrádková J; Krusová D; Jurajda M; Mužík J; Pavlík T; Kaňková K
    Kidney Blood Press Res; 2012; 36(1):200-8. PubMed ID: 23147199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic renal impairment and DDAH2-1151 A/C polymorphism determine ADMA levels in type 2 diabetic subjects.
    Marra M; Marchegiani F; Ceriello A; Sirolla C; Boemi M; Franceschi C; Spazzafumo L; Testa I; Bonfigli AR; Cucchi M; Testa R
    Nephrol Dial Transplant; 2013 Apr; 28(4):964-71. PubMed ID: 23129820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between dimethylarginine dimethylaminohydrolase gene variants and asymmetric dimethylarginine in patients with rheumatoid arthritis.
    Dimitroulas T; Sandoo A; Hodson J; Smith J; Panoulas VF; Kitas GD
    Atherosclerosis; 2014 Nov; 237(1):38-44. PubMed ID: 25194333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AGXT2 and DDAH-1 genetic variants are highly correlated with serum ADMA and SDMA levels and with incidence of coronary artery disease in Egyptians.
    Amir M; Hassanein SI; Abdel Rahman MF; Gad MZ
    Mol Biol Rep; 2018 Dec; 45(6):2411-2419. PubMed ID: 30284143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accelerated onset of senescence of endothelial progenitor cells in patients with type 2 diabetes mellitus: role of dimethylarginine dimethylaminohydrolase 2 and asymmetric dimethylarginine.
    Yuan Q; Hu CP; Gong ZC; Bai YP; Liu SY; Li YJ; Jiang JL
    Biochem Biophys Res Commun; 2015 Mar; 458(4):869-76. PubMed ID: 25701782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for a protective role for the rs805305 single nucleotide polymorphism of dimethylarginine dimethylaminohydrolase 2 (DDAH2) in septic shock through the regulation of DDAH activity.
    Lambden S; Tomlinson J; Piper S; Gordon AC; Leiper J
    Crit Care; 2018 Dec; 22(1):336. PubMed ID: 30538005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ex vivo gene transferring of human dimethylarginine dimethylaminohydrolase-2 improved endothelial dysfunction in diabetic rat aortas and high glucose-treated endothelial cells.
    Lu CW; Guo Z; Feng M; Wu ZZ; He ZM; Xiong Y
    Atherosclerosis; 2010 Mar; 209(1):66-73. PubMed ID: 19775692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association of dimethylarginine dimethylaminohydrolase 1 gene polymorphism with type 2 diabetes: a cohort study.
    Lu TM; Lin SJ; Lin MW; Hsu CP; Chung MY
    Cardiovasc Diabetol; 2011 Feb; 10():16. PubMed ID: 21303562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene transfer of dimethylarginine dimethylaminohydrolase-2 improves the impairments of DDAH/ADMA/NOS/NO pathway in endothelial cells induced by lysophosphatidylcholine.
    Feng M; Liu L; Guo Z; Xiong Y
    Eur J Pharmacol; 2008 Apr; 584(1):49-56. PubMed ID: 18342305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DDAH1 and DDAH2 polymorphisms associate with asymmetrical dimethylarginine plasma levels in erectile dysfunction patients but not in healthy controls.
    Brites-Anselmi G; Azevedo AMM; Miyazaki AHL; Pinheiro LC; Coeli-Lacchini FB; de Andrade MF; Molina CAF; Tucci S; Hirsch E; Tanus-Santos JE; Lacchini R
    Nitric Oxide; 2019 Nov; 92():11-17. PubMed ID: 31394201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severely decreased activity of placental dimethylarginine dimethylaminohydrolase in pre-eclampsia.
    Anderssohn M; Maass LM; Diemert A; Lüneburg N; Atzler D; Hecher K; Böger RH
    Eur J Obstet Gynecol Reprod Biol; 2012 Apr; 161(2):152-6. PubMed ID: 22285683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ADMA reduction does not protect mice with streptozotocin-induced diabetes mellitus from development of diabetic nephropathy.
    Rodionov RN; Heinrich A; Brilloff S; Jarzebska N; Martens-Lobenhoffer J; Bode-Böger SM; Todorov VT; Hugo CPM; Weiss N; Hohenstein B
    Atheroscler Suppl; 2017 Nov; 30():319-325. PubMed ID: 29096857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DDAH gene and cardiovascular risk.
    Valkonen VP; Tuomainen TP; Laaksonen R
    Vasc Med; 2005 Jul; 10 Suppl 1():S45-8. PubMed ID: 16444868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of serum levels of asymmetric dimethylarginine, symmetric dimethylarginine and L-arginine in coronary artery disease.
    Gad MZ; Hassanein SI; Abdel-Maksoud SM; Shaban GM; Abou-Aisha K; Elgabarty HA
    Biomarkers; 2010 Dec; 15(8):746-52. PubMed ID: 20936901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pioglitazone lowers systemic asymmetric dimethylarginine by inducing dimethylarginine dimethylaminohydrolase in rats.
    Wakino S; Hayashi K; Tatematsu S; Hasegawa K; Takamatsu I; Kanda T; Homma K; Yoshioka K; Sugano N; Saruta T
    Hypertens Res; 2005 Mar; 28(3):255-62. PubMed ID: 16097370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of asymmetric dimethylarginine in vascular injury in transgenic mice overexpressing dimethylarginie dimethylaminohydrolase 2.
    Hasegawa K; Wakino S; Tatematsu S; Yoshioka K; Homma K; Sugano N; Kimoto M; Hayashi K; Itoh H
    Circ Res; 2007 Jul; 101(2):e2-10. PubMed ID: 17601800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A functional variant of the dimethylarginine dimethylaminohydrolase-2 gene is associated with myocardial infarction in type 2 diabetic patients.
    Mannino GC; Pezzilli S; Averta C; Fuoco A; Spiga R; Mancuso E; Di Fatta C; Perticone F; Prudente S; Trischitta V; Andreozzi F; Sesti G
    Cardiovasc Diabetol; 2019 Aug; 18(1):102. PubMed ID: 31409409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.